Utah Medical Products, Inc.

Utah Medical Products, Inc.

UTMD
Utah Medical Products, Inc.US flagNASDAQ Global Select
70.71
USD
-0.93
- -
225.14MMarket Cap

Total Valuation

Utah Medical Products, Inc. carries a market capitalization of 225.14M, placing it among publicly traded companies globally. Its enterprise value stands at 219.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap225.14M
Enterprise Value219.63M

Share Statistics

Utah Medical Products, Inc. currently has 3.18M shares outstanding.

Shares Outstanding3.18M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Utah Medical Products, Inc. trades at a trailing price-to-earnings ratio of 28.21.

PE Ratio28.21
PS Ratio7.98
PB RatioN/A
P/TBV RatioN/A
P/FCF Ratio20.80
P/OCF Ratio21.03

Enterprise Valuation

On an enterprise value basis, Utah Medical Products, Inc. trades at an EV/EBITDA multiple of 21.38 and an EV/FCF ratio of 20.73. The EV/Sales ratio of 7.96 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 27.26 provides insight into valuation relative to core operating earnings.

EV / Sales7.96
EV / EBITDA21.38
EV / EBIT27.26
EV / FCF20.73

Financial Position

Utah Medical Products, Inc. maintains a current ratio of 98.32, meaning it holds 98.3x the short-term assets needed to cover near-term liabilities.

Current Ratio98.32
Quick Ratio89.56
Debt / Equity0.57
Debt / EBITDAN/A
Interest CoverageN/A

Financial Efficiency

Utah Medical Products, Inc. posts a return on equity of 13.27 and a return on invested capital of 11.12.

Return on Equity (ROE)13.27
Return on Assets (ROA)12.92
Return on Invested Capital (ROIC)11.12
Return on Capital Employed (ROCE)13.25
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.78

Taxes

Over the trailing twelve months, Utah Medical Products, Inc. has paid 1.80M in income taxes, reflecting an effective tax rate of 18.71.

Income Tax1.80M
Effective Tax Rate18.71

Stock Price Statistics

Utah Medical Products, Inc.'s stock has gained approximately 15.80413% over the past 52 weeks. The 50-day moving average sits at 70.48, while the 200-day moving average is 64.67.

Beta (5Y)N/A
52-Week Price Change15.80413%
50-Day Moving Average70.48
200-Day Moving Average64.67
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Utah Medical Products, Inc. generated 27.58M in revenue and converted that into 7.80M in net income, yielding earnings per share of 2.44. EBITDA reached 10.28M, while operating income came in at 8.06M.

Revenue27.58M
Gross Profit16.15M
Operating Income8.06M
Pretax Income9.60M
Net Income7.80M
EBITDA10.28M
EBIT8.06M
Earnings Per Share (EPS)2.44

Cash Flow

Utah Medical Products, Inc. produced 10.46M in operating cash flow over the past twelve months. After subtracting -130,000.00 in capital expenditures, free cash flow totaled 10.33M - equivalent to 3.24 per share.

Operating Cash Flow10.46M
Capital Expenditures-130,000.00
Free Cash Flow10.33M
FCF Per Share3.24

Margins

Utah Medical Products, Inc. operates with a gross margin of 58.56, reflecting its pricing power and cost economics. The operating margin of 29.22 and net profit margin of 28.29 provide insight into operational efficiency.

Gross Margin58.56
Operating Margin29.22
Pretax Margin34.80
Profit Margin28.29
EBITDA Margin37.26

Dividends & Yields

The company's payout ratio of 37.87 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.93
Dividend YieldN/A
Payout Ratio37.87
Shareholder Yield2.15
FCF Yield4.81

Stock Splits

Utah Medical Products, Inc.'s most recent stock split took place on March 22, 1993 with a 2:3 split ratio.

Last Split Date3/22/1993
Split Ratio2:3

Scores

Utah Medical Products, Inc. posts an Altman Z-Score of 105.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score105.05